SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Lost in translation: learning from preclinical data | Gerry DaviesView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016A Need for altering Tuberculosis Dosing Regiments for patients with HIV-associated Tuberculous Meningitis | G. AljayyoussiView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Sub-therapeutic concentrations of anti-tuberculosis drugs in children when treated according to indian dosing recommendation | B. GuiastrennecView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Early interventions for diabetes related tuberculosis hasten sputum microbiological clearance in Virginia, USA | S. HeysellView Slideset
CPCharles PeloquinPharmDSlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Charles Peloquin, PharmDView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Lung Tissue Concentrations of Pyrazinamide among Patients with Tuberculosis | R. KempkerView Slideset
SlidesetViral Hepatitis and Liver DiseaseSymposium on Key Issues in Liver Transplantation for NASH 2016How should we optimize immunosuppression? - Kittie Wynne, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseSymposium on Key Issues in Liver Transplantation for NASH 2016What is an acceptable BMI - Lee Kaplan, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseSymposium on Key Issues in Liver Transplantation for NASH 2016Can Bariatric surgery convert a non-candidate to a candidate? - Julie Heimbachx, MDView Slideset
DMDmitry ManuilovMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MDView Slideset
DMDouglas MayersMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MDView Slideset
MMMatthew McClureMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021STOPS Agents - M. McClure, MDView Slideset
